BioCatalyst

Odevixibat — catalyst calendar

2 verified catalyst event(s) referencing Odevixibat, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-28
in 1mo
ESTIMATED
 READOUT
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevi
Phase 3 · Biliary Atresia
 Albireo, an Ipsen Company Odevixibat ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Phase 3 · Alagille Syndrome
 Albireo, an Ipsen Company Odevixibat ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.